Overall, we demonstrate that an increase in absolute value for circulating CD34-positive cells greater than the threshold of 10/μL in peripheral blood was highly indicative of secondary myelofibrosis in PV/ET patients during follow-up. This evidence concerns the gene CD34 and essential thrombocythemia.